Effect of prenatal zinc supplementation on adipose tissue-derived hormones and neonatal weight, height and head circumference in women with impaired glucose tolerance test: randomized clinical controlled trial

International Journal of Diabetes in Developing Countries

Volumn 39, Issue 3, 2019, Pages 471-477

  Roshanravan, Neda ^a,b   Alizadeh, Mohammad ^b   Asghari Jafarabadi, Mohammad ^c,d   Alamdari, Naimeh Mesri ^e   Mohammadi, Hamed ^f   Farrin, Nazila ^b   Tarighat Esfanjani, Ali ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Leptin; Pregnancy; Visfatin; Zinc; Zinc 2 glycoprotein

Indexed keywords

ADIPONECTIN; ALPHA2 GLYCOPROTEIN; GLUCONATE ZINC; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLACEBO; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE TOLERANCE TEST; HEAD CIRCUMFERENCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE TEST; IRAN; PREGNANT WOMAN; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL;

EID: 85070248731     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-018-0707-1     Document Type: Article

References (63)

1. Bo S, Lezo A, Menato G, Gallo M-L, Bardelli C, Signorile A, et al. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition. 2005;21(2):186–91.
2. Ryan E. Diagnosing gestational diabetes. Diabetologia. 2011;54(3):480–6.
3. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46(12):1594–603.
4. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.
5. Tessier D, Ferraro Z, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34(3):205–11.
6. Schubring C, Englaro P, Siebler T, Blum W, Demirakca T, Kratzsch J, et al. Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels. Horm Res Paediatr. 1999;50(5):276–83.
7. Sun Z, Lei H, Zhang Z. Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions. Cytokine Growth Factor Rev. 2013;24(5):433–42.
8. Ferreira AFA, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem. 2011;57(4):609–13.
9. Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, et al. Visfatin in human pregnancy: maternal gestational diabetes Vis-a-Vis neonatal birthweight. J Perinat Med. 2009;37(3):218–31.
10. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci. 2006;110:605–9.
11. Akturk M, Altinova A, Mert I, Buyukkagnici U, Sargin A, Arslan M, et al. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Investig. 2008;31(7):610–3.
12. Haider DG, Handisurya A, Storka A, Vojtassakova E, Luger A, Pacini G, et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care. 2007;30(7):1889–91.
13. Ceperuelo-Mallafré V, Naf S, Escoté X, Caubet E, Gomez J, Miranda M, et al. Circulating and adipose tissue gene expression of zinc-α2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab. 2009;94(12):5062–9.
14. Garrido-Sánchez L, García-Fuentes E, Fernández-García D, Escoté X, Alcaide J, Perez-Martinez P, et al. Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients. PLoS One. 2012;7(3):e33264.
15. Russell ST, Tisdale MJ. Antidiabetic properties of zinc-α2-glycoprotein in Ob/Ob mice. Endocrinology. 2010;151(3):948–57.
16. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–91.
17. Kinalski M, Telejko B, Kuźmicki M, Krętowski A, Kinalska I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res. 2005;37(07):450–4.
18. Khandouzi M, Deka M. The role of adiponectin in human pregnancy
19. Vrachnis N, Belitsos P, Sifakis S, Dafopoulos K, Siristatidis C, Pappa KI, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol. 2012;2012:1–12.
20. Konukoglu D, Turhan MS, Ercan M, Serin O. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem. 2004;15(12):757–60.
21. Islam MR, Arslan I, Attia J, McEvoy M, McElduff P, Basher A, et al. Is serum zinc level associated with prediabetes and diabetes?: a cross-sectional study from Bangladesh. PLoS One. 2013;8(4):e61776.
22. Åberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol. 2001;184(2):77–83.
23. Hossein-Nezhad A, Maghbooli Z, Vassigh A-R, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwanese J Obstet Gynecol. 2007;46(3):236–41.
24. Association AD. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37:S14–80.
25. Kim J, Lee S. Effect of zinc supplementation on insulin resistance and metabolic risk factors in obese Korean women. Nutr Res Pract. 2012;6(3):221–5.
26. Hamadani JD, Fuchs GJ, Osendarp SJ, Huda SN, Grantham-McGregor SM. Zinc supplementation during pregnancy and effects on mental development and behaviour of infants: a follow-up study. Lancet. 2002;360(9329):290–4.
27. Shrimpton R, Gross R, Darnton-Hill I, Young M. Zinc deficiency: what are the most appropriate interventions? BMJ. 2005;330(7487):347–9.
28. Wiernsperger N, Rapin J. Trace elements in glucometabolic disorders: an update. Diabetol Metab Syndr. 2010;2(70):1–9.
29. Sun Q, Van Dam RM, Willett WC, Hu FB. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care. 2009;32(4):629–34.
30. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol. 1997;47(1):101–6.
31. Chen M-D, Song Y-M, Lin P-Y. Zinc may be a mediator of leptin production in humans. Life Sci. 2000;66(22):2143–9.
32. Bribiescas RG. Effects of oral zinc supplementation on serum leptin levels in ache males of eastern Paraguay. Am J Hum Biol. 2003;15(5):681–7.
33. Argani H, Mahdavi R, Ghorbani-haghjo A, Razzaghi R, Nikniaz L, Gaemmaghami SJ. Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients. J Trace Elem Med Biol. 2014;28(1):35–8.
34. Marrades M, Martinez J, Moreno-Aliaga M. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem. 2008;64(1):61–6.
35. Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J et al. The aipokine zinc-a2-glycoprotein is down regulated with fat mass expansion in obesity.
36. Fain JN, Bahouth SW. Regulation of leptin release by mammalian adipose tissue. Biochem Biophys Res Commun. 2000;274(3):571–5.
37. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology. 1997;138(10):4463–72.
38. Roshanravan N, Alizadeh M, Hedayati M, Asghari-Jafarabadi M, Alamdari NM, Anari F, et al. Effect of zinc supplementation on insulin resistance, energy and macronutrients intakes in pregnant women with impaired glucose tolerance. Iran J Public Health. 2015;44(2):211–7.
39. Näf S, Escote X, Yañez RE, Ballesteros M, Simón I, Gil P, et al. Zinc-α2-glycoprotein is unrelated to gestational diabetes: anthropometric and metabolic determinants in pregnant women and their offspring. PLoS One. 2012;7(12):e47601.
40. Selva DMLA, Herna’ndez C, Baena JA, Fort JM, Simo R. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab. 2009;94(11):8.
41. Gong F, Zhang S, Deng J, Zhu H, Pan H, Li N, et al. Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes. 2009;33(9):1023–30.
42. Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc-α2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab. 2009;94(7):2531–6.
43. Stejskal D, Karpíšek M, Reutova H, Stejskal P, Kotolova H, Kollár P. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem. 2008;41(4):313–6.
44. Wang C. Obesity, inflammation, and lung injury (OILI): the good. Mediat Inflamm. 2014;2014:1–15.
45. Russell ST, Tisdale MJ. Studies on the antiobesity effect of zinc-α2-glycoprotein in the Ob/Ob mouse. Int J Obes. 2010;35(3):345–54.
46. Lewandowski K, Stojanovic N, Press M, Tuck S, Szosland K, Bienkiewicz M, et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia. 2007;50(5):1033–7.
47. Mastorakos G, Valsamakis G, Papatheodorou DC, Barlas I, Margeli A, Boutsiadis A, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007;53(8):1477–83.
48. Ma Y, Cheng Y, Wang J, Cheng H, Zhou S, Li X. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract. 2010;90(1):60–5.
49. Zhaoxia L, Ying W, Danqing C. Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus. Diabetes Res Clin Pract. 2012;96(3):e76–e9.
50. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier J-C, Huston-Presley L, Friedman JE, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51(7):2207–13.
51. McLachlan KA, O'Neal D, Jenkins A, Alford FP. Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22(2):131–8.
52. Coughlan M, Oliva K, Georgiou H, Permezel J, Rice G. Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med. 2001;18(11):921–7.
53. Yalçın SS, Engür-Karasimav D, Alehan D, Yurdakök K, Özkutlu S, Coşkun T. Zinc supplementation and TNF-α levels in vaccinated cardiac patients. J Trace Elem Med Biol. 2011;25(2):85–90.
54. Kara E, Ozal M, Gunay M, Kilic M, Baltaci AK, Mogulkoc R. Effects of exercise and zinc supplementation on cytokine release in young wrestlers. Biol Trace Elem Res. 2011;143(3):1435–40.
55. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(6):646–52.
56. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev. 2003;14(5):447–55.
57. Wójcik M, Chmielewska-Kassassir M, Grzywnowicz K, Woźniak L, Cypryk K. The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol Pol. 2014;65(2):134–42.
58. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11_supplement_1):s64–73.
59. Kajantie E, Hytinantti T, Hovi P, Andersson S. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab. 2004;89(8):4031–6.
60. Merialdi M, Caulfield LE, Zavaleta N, Figueroa A, Costigan KA, Dominici F, et al. Randomized controlled trial of prenatal zinc supplementation and fetal bone growth. Am J Clin Nutr. 2004;79(5):826–30.
61. Caulfield LE, Zavaleta N, Figueroa A, Leon Z. Maternal zinc supplementation does not affect size at birth or pregnancy duration in Peru. J Nutr. 1999;129(8):1563–8.
62. Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr. 1998;68(2):499S–508S.
63. Garg H, Singhal K. Arshad Z. a study of the effect of oral zinc supplementation during pregnancy on pregnancy outcome. Indian J Physiol Pharmacol. 1993;37(4):276–84.